FIELD: medicine.
SUBSTANCE: what is presented is using hypaconitine (a heterocyclic nitrogen organic compound recovered from plants of the genus Aconitum of the family Ranunculaceae with the known analgesic activity) as a cerebroprotective agent. The mode of action of the agent is activation of cerebral neural stem cells.
EFFECT: prevented animal death following suffered hypoxia.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2497540C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
MEDICATION, POSSESSING WOUND-HEALING ACTIVITY | 2012 |
|
RU2481836C1 |
AN ANTIHYPOXIC AGENT | 1996 |
|
RU2121357C1 |
ACTIVE INGREDIENT OF MEDICINAL AGENT WITH CEREBROPROTECTIVE, ANTIHYPOXIC AND ANTIAMNESTIC ACTIVITY FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND METHOD FOR PREPARING THE SAME | 2023 |
|
RU2821508C1 |
Authors
Dates
2014-05-27—Published
2013-03-12—Filed